VGA039 offers exciting potential as a subcutaneous therapy for #VWD. The high bioavailability and favorable pharmacokinetic profile suggest it may have a product profile for infrequent, subcutaneous dosing for the treatment of VWD prophylaxis.
Star Therapeutics
Biotechnology Research
South San Francisco, California 2,247 followers
In a universe of possibilities, we see things differently.
Über uns
Star Therapeutics is a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible for the millions of patients in urgent need. Our innovation engine starts with identifying multiple rare diseases that share a common biology and then discovering novel therapeutics that can treat these diseases with a single therapy. Star consists of a family of companies, each focusing on a specific area of novel biology and developing first-in-class antibody therapeutics. Electra Therapeutics, the first company within our portfolio to be unveiled, is developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.
- Website
-
http://star-therapeutics.com
External link for Star Therapeutics
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- South San Francisco, California
- Typ
- In Privatbesitz
Standorte
-
Primäre
Wegbeschreibung erhalten
South San Francisco, California 94080, US
Employees at Star Therapeutics
Aktualisierungen
-
If you're attending #BIO2024, we invite you to check out a panel session on exploring deal-making options for your portfolio of assets. Star CEO and founder Adam Rosenthal will be a member of the panel chaired by Thomas Marron that will also include Caroline Stark Beer, James Mutamba, and Bassil Dahiyat. We hope to see you in San Diego!
-
-
In honor of Women and Girls in Science Day, we celebrate the brilliant minds that will shape the future of science and technology. #STEM #WomenandGirlsinScience #InspiringInnovation
-
-
Excited to see Scott Robertson's name in lights on the Nasdaq Tower in Times Square!
-
-
Our CEO and Founder Adam Rosenthal will be presenting a corporate overview today at #JPM24 . Hope to see you there!
-
-
Join us in welcoming Scott Robinson to the Star team as our Chief Financial Officer and Chief Business Officer.
Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer - STAR Therapeutics
https://star-therapeutics.com
-
Hope to see you at JPM 2024 in San Francisco where Adam Rosenthal Ph.D., our CEO and Founder, will present a company overview.
Star Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference - STAR Therapeutics
https://star-therapeutics.com
-
Congratulations to Kathy Dong on her appointment as CEO of Electra Therapeutics. Be sure to check out this article from Fierce Biotech.
Rare disease biotech Electra picks commercially-minded Kathy Dong as next CEO
fiercebiotech.com
-
We’re excited to welcome Matthew Fust as a member of our board at this exciting time of growth potential across the Star Therapeutics family of companies.
Star Therapeutics Appoints Matthew Fust as Independent Director and Audit Chair - STAR Therapeutics
https://star-therapeutics.com
-
Be sure to check out the article in Bioworld about our recent financing which positions us to fuel further growth and build on our success. #UniverseOfPossibilities #VWD
Promising Star formations draw investors in $90M oversubscribed series C
bioworld.com